Ligand-enabled reactivity and selectivity in a synthetically versatile Aryl C-H olefination

Science

Volumn 327, Issue 5963, 2010, Pages 315-319

  Wang, Dong Hui ^a   Engle, Keary M ^a   Shi, Bing Feng ^a   Yu, Jin Quan ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID DERIVATIVE; CARBON; CARBOXYLIC ACID; HYDROCINNAMIC ACID; LIGAND; NAPHTHALENE DERIVATIVE; NATURAL PRODUCT; OXIDIZING AGENT; OXYGEN; PALLADIUM; PHENYLACETIC ACID; POLYCYCLIC AROMATIC HYDROCARBON DERIVATIVE; TETRALIN DERIVATIVE;

AMINO ACID; CARBOXYLIC ACID; CATALYSIS; CHEMICAL BONDING; DRUG; HALIDE; KETONE; LIGAND; OXIDANT;

ARTICLE; ATMOSPHERIC PRESSURE; ATOM; CATALYSIS; CHEMICAL REACTION; HYDROGEN BOND; OLEFINATION; PRIORITY JOURNAL; SYNTHESIS;

ALKENES; AMINO ACIDS; CARBON; CARBOXYLIC ACIDS; CATALYSIS; HYDROGEN; LIGANDS; MOLECULAR STRUCTURE; NAPHTHALENES; OXIDANTS; OXYGEN; PALLADIUM; PHENYLACETATES; PHENYLPROPIONATES; PHYSICOCHEMICAL PROCESSES; TETRALONES;

EID: 74549148904     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.1182512     Document Type: Article

References (37)

1. J. F. Hartwig, Nature 455, 314 (2008).
2. A. R. Dick, M. S. Sanford, Tetrahedron 62, 2439 (2006).
3. O. Daugulis, V. G. Zaitsev, D. Shabashov, Q.-N. Pham, A. Lazareva, Synlett 2006, 3382 (2006).
4. L.-C. Campeau, D. R. Stuart, K. Fagnou, Aldrichim. Acta 40, 35 (2007).
5. J.-Q. Yu, R. Giri, X. Chen, Org. Biomol. Chem. 4, 4041 (2006).
6. B. D. Dangel, K. Godula, S. W. Youn, B. Sezen, D. Sames, J. Am. Chem. Soc. 124, 11856 (2002).
7. A. Hinman, J. Du Bois, J. Am. Chem. Soc. 125, 11510 (2003).
8. A. L. Bowie Jr., C. C. Hughes, D. Trauner, Org. Lett. 7, 5207 (2005).
9. H. M. L. Davies, X. Dai, M. S. Long, J. Am. Chem. Soc. 128, 2485 (2006).
10. A. S. Tsai, R. G. Bergman, J. A. Ellman, J. Am. Chem. Soc. 130, 6316 (2008).
11. K. Chen, P. S. Baran, Nature 459, 824 (2009).
12. E. M. Stang, M. C. White, Nat. Chem. 1, 547 (2009).
13. K. C. Nicolaou, P. G. Bulger, D. Sarlah, Angew. Chem. Int. Ed. 44, 4442 (2005).
14. B. M. Trost, S. A. Godleski, J. P. Genet, J. Am. Chem. Soc. 100, 3930 (1978).
15. P. S. Baran, E. J. Corey, J. Am. Chem. Soc. 124, 7904 (2002).
16. N. K. Garg, D. D. Caspi, B. M. Stoltz, J. Am. Chem. Soc. 126, 9552 (2004).
17. E. M. Beck, R. Hatley, M. J. Gaunt, Angew. Chem. Int. Ed. 47, 3004 (2008).
18. R. J. Phipps, M. J. Gaunt, Science 323, 1593 (2009).
19. Y.-H. Zhang, B.-F. Shi, J.-Q. Yu, J. Am. Chem. Soc. 131, 5072 (2009).
20. For early examples of Pd-catalyzed directed and nondirected arene C-H olefination, see (31-33). For an early example of Ru-catalyzed directed olefination, see (34).
21. T.-S. Mei, R. Giri, N. Maugel, J.-Q. Yu, Angew. Chem. Int. Ed. 47, 5215 (2008).
22. D.-H. Wang, T.-S. Mei, J.-Q. Yu, J. Am. Chem. Soc. 130, 17676 (2008).
23. P. Beak, V. Snieckus, Acc. Chem. Res. 15, 306 (1982).
24. For application of mono-N-protected amino acid ligands for Pd-catalyzed enantioselective C-H activation/C-C cross coupling, see (35).
25. A. G. Myers, Y. Horiguchi, Tetrahedron Lett. 38,4363 (1997).
26. N. Ji, B. M. Rosen, A. G. Myers, Org. Lett. 6, 4551 (2004).
27. S. Kawata, S. Ashizawa, M. Hirama, J. Am. Chem. Soc. 119, 12012 (1997).
28. F. C. Görth, M. Rucker, M. Eckhardt, R. Brückner, Eur, J. Org, Chem. 2000, 2605 (2000).
29. Á. Gorka et al., Synth. Commun. 35, 2371 (2005).
30. For discussion of the importance of ligand development in Pd chemistry, see (36).
31. M. Miura, T. Tsuda, T. Satoh, S. Pivsa-Art, M. Nomura, J. Org. Chem. 63, 5211 (1998).
32. C. G. Jia et al., Science 287, 1992 (2000).
33. M. D. K. Boele et al., J. Am. Chem. Soc. 124,1586 (2002).
34. S. Murai et al., Nature 366, 529 (1993).
35. B.-F. Shi, N. Maugel, Y.-H. Zhang, J.-Q. Yu, Angew. Chem. Int. Ed. 47, 4882 (2008).
36. R. Martin, S. L. Buchwald, Acc. Chem. Res. 41,1461 (2008).
37. Supported by an A. P. Sloan Foundation fellowship (J.-Q.Y.); predoctoral fellowships from NSF, the U.S. Department of Defense, the Scripps Research Institute, and the Skaggs Oxford Scholarship program (K.M.E.); and the Scripps Research Institute, National Institute of General Medical Sciences grant 1 RO1 GM084019-02, NSF grant CHE-0910014, Amgen, and Eli Lilly & Co.